What is Arcus Biosciences's cash ratio?

Arcus Biosciences (RCUS) reported cash ratio of 1× in Q1 2026.

How has Arcus Biosciences's cash ratio changed year-over-year?

Arcus Biosciences's cash ratio decreased by 3.8% year-over-year, from 1× to 1×.

What is the long-term trend for Arcus Biosciences's cash ratio?

Over 5 years (2020 to 2025), Arcus Biosciences's cash ratio has grown at a -7.6% compound annual growth rate (CAGR), from 1.4× to 1×.

What does cash ratio mean?

Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.

Arcus Biosciences RCUS Cash ratio

Cash ratio at other companies

Bristol-Myers SquibbBMY

0.5×0.0×

Merck & Co.MRK

0.2×-0.1×

Regeneron PharmaceuticalsREGN

0.6×-0.3×

AbbVieABBV

0.2×+0.1×

IDEAYA Biosciences, Inc.IDYA

2.4×-0.1×

IncyteINCY

2.3×+1.2×

Other financials

Income statement

See full

Revenue$17.0M-39.3%

Operating income-$134.0M-9.8%

Net income-$128.0M-14.3%

EPS (diluted)-$1.02+10.5%

Balance sheet

See full

Cash & equivalents$201.0M+4.7%

Total debt$113.0M+88.3%

Total equity$524.0M-1.3%

Total assets$997.0M-13.8%

Cash flow

See full

Operating cash flow-$138.0M-4.5%

CapEx--100%

Free cash flow-$138.0M-3.8%

Valuation

See full

Market cap$3.54B+226%

Enterprise value$3.46B+275%

P/S15×+7.3×

Profitability

See full

Operating margin-168.6%-52.7pp

Net margin-156.4%-47.5pp

FCF margin-207.2%—

Returns & leverage

See full

Return on equity-70%+8.4pp

Debt / equity0.2×+0.1×

Current ratio4×-1.3×

Where this comes from

Calculated from Arcus Biosciences’s reported figures.

cash and equivalents/total current liabilities=1×

Based on the most recent quarter.

The official record: Arcus Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arcus Biosciences's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Arcus Biosciences's cash ratio?: Arcus Biosciences (RCUS) reported cash ratio of 1× in Q1 2026.
How has Arcus Biosciences's cash ratio changed year-over-year?: Arcus Biosciences's cash ratio decreased by 3.8% year-over-year, from 1× to 1×.
What is the long-term trend for Arcus Biosciences's cash ratio?: Over 5 years (2020 to 2025), Arcus Biosciences's cash ratio has grown at a -7.6% compound annual growth rate (CAGR), from 1.4× to 1×.
What does cash ratio mean?: Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.